The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
the few successes that we had seen hodgkin's disease a few non-hodgkin's lymphomas or acute promyelocytic leukemia chronic myeloid leukemia i mean my multiple myeloma now has been very successfully treated but at that time it wasn't but now it is definitely a night and day difference but these are again rare types of cancers melanoma dramatic differences in survival today but again all of these together would account for less than 10 percent of cancers together
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.